Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: A Belgian retrospective multicentre study

Benhadou, Farida;Ghislain, Pierre-Dominique;Guiot, Françoise;Willaert, Fabienne;de la Brassinne, Michel;et.al.
(2020) Journal of the European Academy of Dermatology and Venereology — Vol. 34, n° 12, p. e837-e839 (2020)

Files

Accepted_Article.pdf
  • Open Access
  • Adobe PDF
  • 49.6 KB
Download

Details

Authors
  • Benhadou, Farida
    Author
  • Ghislain, Pierre-DominiqueUCLouvain
    Author
  • Guiot, Françoise
    Author
  • Willaert, Fabienne
    Author
  • de la Brassinne, Michel
    Author
Show more
Abstract
(en) Dear Editor, We read with great interest the multicenter and retrospective study of Fougerosse et al1 that investigated real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. In the same manner, we conducted the first multicenter study in Belgium aiming to investigate real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Benhadou, F., Ghislain, P.-D., Guiot, F., Willaert, F., Soenen, R., Fierens, H., & de la Brassinne, M. (2020). Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: A Belgian retrospective multicentre study. Journal of the European Academy of Dermatology and Venereology, 34(12), e837-e839. https://doi.org/10.1111/jdv.16715 (Original work published 2020)